Skip to main content

Table 6 Factors associated with service use in the 12 months of life, N = 68,523

From: Primary care service use by end-of-life cancer patients: a nationwide population-based cohort study in the United Kingdom

Variable

Value

GP consultationa

 

GP prescriptionb

 

Palliative care

Yes

1.30(1.29 to 1.32)

< 0.0001

1.17(1.16 to 1.18)

< 0.0001

Age at death (ref: < 50)

50–59

0.98(0.95 to 1.01)

< 0.0001

1.09(1.04 to 1.13)

< 0.0001

60–69

0.97(0.95 to 1.00)

 

1.21(1.16 to 1.25)

 

70–79

0.95(0.93 to 0.98)

 

1.26(1.22 to 1.31)

 

80–89

0.90(0.88 to 0.93)

 

1.28(1.23 to 1.33)

 

90+

0.85(0.83 to 0.88)

 

1.34(1.29 to 1.40)

 

Gender (ref: female)

Male

0.96(0.95 to 0.97)

< 0.0001

0.93(0.91 to 0.94)

< 0.0001

Cancer site (ref: Lung)

Colorectal

1.01(1.00 to 1.03)

< 0.0001

1.06(1.04 to 1.08)

< 0.0001

Breast

1.04(1.03 to 1.05)

 

0.97(0.96 to 0.99)

 

Prostate

1.22(1.20 to 1.24)

 

1.15(1.13 to 1.17)

 

No. comorbidity conditions (ref: 0)

1

1.09(1.08 to 1.11)

< 0.0001

1.20(1.18 to 1.22)

< 0.0001

2

1.21(1.19 to 1.22)

 

1.43(1.40 to 1.45)

 

3

1.30(1.28 to 1.32)

 

1.62(1.59 to 1.65)

 

4+

1.42(1.39 to 1.44)

 

1.92(1.88 to 1.95)

 

Time between diagnosis and death (months) (ref: 120+)

< 6

1.06(1.03 to 1.09)

< 0.0001

0.99(0.95 to 1.02)

 

6–12

1.27(1.23 to 1.31)

 

1.09(1.05 to 1.12)

< 0.0001

13–36

1.09(1.06 to 1.11)

 

1.06(1.03 to 1.10)

 

37–60

1.04(1.01 to 1.07)

 

1.04(1.01 to 1.07)

 

61–120

1.00(0.97 to 1.03)

 

1.00(0.97 to 1.03)

 

Year of death (ref: 2010–2014)

2000–2004

0.63(0.61 to 0.65)

< 0.0001

0.82(0.81 to 0.84)

< 0.0001

2005–2009

0.87(0.85 to 0.88)

 

0.93(0.91 to 0.94)

 

Region (ref: England)

Wales

0.98(0.92 to 1.04)

< 0.0001

1.14(1.09 to 1.19)

< 0.0001

Scotland

1.13(1.06 to 1.20)

 

0.98(0.94 to 1.02)

 

NI

1.57(1.43 to 1.71)

 

1.15(1.07 to 1.24)

 
  1. a including all consultations (i.e. direct & indirect patient contacts); bprescriptions of unique products only